UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

23 May 2023

UCB and Veeva collaborate to advance the patient experience in clinical trials

Read More
11 May 2023

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

Read More
27 Apr 2023

UCB’s General Meeting of Shareholders 2023

Read More
27 Apr 2023

UCB Receives Positive CHMP Opinions for Bimekizumab for the Treatment of Adults with Psoriatic Arthritis and Axial Spondyloarthritis in the European Union

Read More
20 Apr 2023

UCB Showcases Strength and Depth of Neurology Portfolio at 75th American Academy of Neurology (AAN) Annual Meeting

Read More
13 Apr 2023

UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal

Read More

Stay up-to-date on the latest news and information from UCB